PAPPALARDO, FEDERICO
 Distribuzione geografica
Continente #
AS - Asia 4.480
EU - Europa 4.243
NA - Nord America 2.791
SA - Sud America 1.210
AF - Africa 71
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.806
Nazione #
US - Stati Uniti d'America 2.655
RU - Federazione Russa 2.507
SG - Singapore 1.675
CN - Cina 1.424
BR - Brasile 1.028
SE - Svezia 643
HK - Hong Kong 544
VN - Vietnam 423
IT - Italia 375
FR - Francia 245
DE - Germania 129
BD - Bangladesh 103
GB - Regno Unito 86
IN - India 80
AR - Argentina 71
CA - Canada 68
FI - Finlandia 63
AT - Austria 37
EC - Ecuador 36
IE - Irlanda 33
MX - Messico 33
IQ - Iraq 30
ID - Indonesia 29
PL - Polonia 26
ES - Italia 25
CO - Colombia 23
TR - Turchia 23
ZA - Sudafrica 20
PK - Pakistan 19
PY - Paraguay 18
JP - Giappone 16
NL - Olanda 15
UA - Ucraina 15
MY - Malesia 13
UZ - Uzbekistan 12
VE - Venezuela 12
MA - Marocco 11
SA - Arabia Saudita 11
TN - Tunisia 11
CL - Cile 10
KE - Kenya 10
AE - Emirati Arabi Uniti 9
OM - Oman 8
CH - Svizzera 7
DO - Repubblica Dominicana 7
HN - Honduras 7
MD - Moldavia 7
UY - Uruguay 7
AZ - Azerbaigian 6
EG - Egitto 6
GT - Guatemala 6
CY - Cipro 5
JO - Giordania 5
KG - Kirghizistan 5
NP - Nepal 5
AU - Australia 4
DZ - Algeria 4
IL - Israele 4
KW - Kuwait 4
PE - Perù 4
PH - Filippine 4
TT - Trinidad e Tobago 4
AL - Albania 3
BE - Belgio 3
EU - Europa 3
GR - Grecia 3
JM - Giamaica 3
KR - Corea 3
LT - Lituania 3
PT - Portogallo 3
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
EE - Estonia 2
HR - Croazia 2
IR - Iran 2
LB - Libano 2
MN - Mongolia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RO - Romania 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AI - Anguilla 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GE - Georgia 1
KZ - Kazakistan 1
Totale 12.793
Città #
Singapore 636
Moscow 557
Hong Kong 542
San Jose 436
Dallas 357
Ashburn 339
Shanghai 291
Hefei 235
Princeton 225
Lawrence 224
Lauterbourg 203
Beijing 148
Ho Chi Minh City 143
New York 128
Milan 103
Hanoi 91
São Paulo 89
Los Angeles 69
Helsinki 54
Nuremberg 41
Rome 37
Rio de Janeiro 35
Santa Clara 32
Dublin 31
Orem 27
Boardman 26
Haiphong 23
Montreal 23
Vienna 23
Warsaw 21
Brooklyn 20
Da Nang 20
The Dalles 20
Atlanta 19
Phoenix 19
Brasília 18
Chennai 18
Turin 18
Curitiba 17
Stockholm 17
Belo Horizonte 16
Guangzhou 16
Chicago 15
Las Vegas 15
Quito 15
Columbus 14
Mexico City 14
Pune 14
Denver 13
Poplar 13
Porto Alegre 13
Tokyo 13
Toronto 13
Campinas 12
Houston 12
London 12
Munich 12
Salvador 12
Frankfurt am Main 11
Tashkent 11
Thái Bình 11
Boston 10
Dhaka 10
Fortaleza 10
Mapello 10
San Francisco 10
Tianjin 10
Ankara 9
Guarulhos 9
Johannesburg 9
Philadelphia 9
Uberlândia 9
Xi'an 9
Asunción 8
Bogotá 8
Guayaquil 8
Hangzhou 8
Manchester 8
Nairobi 8
Palermo 8
Santo André 8
Bauru 7
Biên Hòa 7
Bologna 7
Cesano Boscone 7
Hải Dương 7
Lahore 7
Magé 7
Shenzhen 7
Shijiazhuang 7
Turku 7
Washington 7
Wuxi 7
Baghdad 6
Calgary 6
Changsha 6
Chengdu 6
Contagem 6
Falkenstein 6
Florence 6
Totale 5.956
Nome #
470 MYOCARDIAL FIBROSIS IN ASYMPTOMATIC PATIENTS UNDERGOING SURGERY FOR MITRAL AND AORTIC VALVE REGURGITATION 202
A meta-analysis of complications and mortality of extracorporeal membrane oxygenation 143
Afterload mismatch after MitraClip insertion for functional mitral regurgitation 129
Abdominal Compartment Syndrome During Extracorporeal Membrane Oxygenation 110
Levosimendan for Hemodynamic Support after Cardiac Surgery 108
Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study 104
A new phosphorylcholine-coated polymethylpentene oxygenator for extracorporeal membrane oxygenation: a preliminary experience 102
Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization 98
Optimal versus suboptimal mitral valve repair: late results in a matched cohort study 98
Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration 94
Anticoagulation for Critically Ill Cardiac Surgery Patients: Is Primary Bivalirudin the Next Step? 93
A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury 91
Acute right ventricular failure post ascending aorta surgery 89
Bleeding in patients with continuous-flow left ventricular assist devices: acquired von Willebrand disease or antithrombotics? 87
Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices 86
An unusual cause of cardiogenic shock: tricuspid regurgitation and right ventricular perforation due to vena cava filter migration 86
An Unusual "Swinging" Biatrial Mass 85
2012 pandemic flu 85
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 84
Adjunctive therapies during veno-venous extracorporeal membrane oxygenation 83
Analysis Of The Effect Of Component Elements Of Hemodynamic Shear Stress Profiles On Shear-Mediated Platelet Activation In Cardiovascular Implantable Therapeutic Devices 82
EARLY DIAGNOSIS OF PUMP THROMBOSIS BASED ON TIME-FREQUENCY ANALYSIS OF LOG-FILES OF THE HEARTWARE HVAD VENTRICULAR ASSIST DEVICE 82
2019 EACTS Expert Consensus on long-term mechanical circulatory support 82
Different anesthesiological management in two high risk pregnant women with heart failure undergoing emergency cesarean section 81
Anesthetic management of transcatheter aortic valve implantation with transaxillary approach. 81
Primary anticoagulation with bivalirudin for patients with implantable ventricular assist devices 79
Can we predict the thrombotic risk in patients with left ventricular assist devices? 79
A narrative review of the technical standards for extracorporeal life support devices (pumps and oxygenators) in Europe 79
Weaning from veno-venous extracorporeal membrane oxygenation: How I do it 79
Predictors of atrial fibrillation after off-pump coronary artery bypass graft surgery 76
Aortic Cannula Disruption Following Long-Term LVAD Support. 76
ECG changes after CABG: the role of the surgical technique 75
Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional Experience 73
Mechanical chest compression and extracorporeal life support for out-of-hospital cardiac arrest. A 30-month observational study in the metropolitan area of Milan, Italy 72
Human protein C concentrate in pediatric septic patients 71
β-Blockers to optimize peripheral oxygenation during extracorporeal membrane oxygenation: a case series 70
Performing chronic hemodialysis therapy in a patient with total artificial heart. 69
Inflow cannula obstruction of the HeartWare left ventricular assist device: what do we really know? 69
High Frequency Components of Hemodynamic Shear Stress Profiles are a Major Determinant of Shear-Mediated Platelet Activation in Therapeutic Blood Recirculating Devices. 68
Loss of Leaflet Insertion After Percutaneous Mitral Valve Repair Requiring Left Ventricular Assist Device Implantation: Usefulness of 3D Multiplanar Reconstruction 68
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. 67
Veno-venous extracorporeal membrane oxygenation in the surgical management of post-traumatic intrathoracic tracheal transection 67
Surgical transaxillary placement of the Impella 5.0 ventricular assist device 67
Bedside insertion of impella percutaneous ventricular assist device in patients with cardiogenic shock 66
Off-pump coronary artery bypass grafting reduces postoperative neurologic complications 66
Myocardial necrosis biomarkers after different cardiac surgical operations 65
Protein C zymogen in adults with severe sepsis or septic shock 65
Timing and Strategy for Weaning From Venoarterial ECMO are Complex Issues 65
Temperature management during off-pump coronary artery bypass graft surgery: a randomized clinical trial on the efficacy of a circulating water system versus a forced-air system 65
Blood Purification With CytoSorb in Critically Ill Patients: Single-Center Preliminary Experience 65
Log Files of Continuous-Flow Left Ventricular Assist Devices Reveal Diurnal Changes of Pump Parameters Beyond Circadian Variations 65
Thrombogenic Potential Of Altered Hemodynamics At The Left Ventricular Apex-LVAD Cannula Interface: A Numerical Study 64
The extracorporeal life support organization Maastricht treaty for nomenclature in extracorporeal life support a position paper of the extracorporeal life support organization 64
Impella Support for Acute Myocardial Infarction complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis 64
Left Ventricular Assist Device Outflow Conduit Fissuration: Endovascular Salvage 64
Shear-mediated platelet activation in patients implanted with continuous flow LVADs: A preliminary study utilizing the platelet activity state (PAS) assay. 63
Cardiac index assessment by the pressure recording analytic method in unstable patients with atrial fibrillation 63
Influence of Different Antithrombotic Regimens on Platelet-Mediated Thrombin Generation in Patients with Left Ventricular Assist Devices 63
Extracorporeal membrane oxygenation to resuscitate a 14-year-old boy after 43min drowning 62
Use of a parallel stiff wire to facilitate percutaneous Impella RP ventricular assist device positioning 62
Underreporting of conversion from off-pump coronary artery bypass surgery 61
Peripheral VA-ECMO venous cannulation: which side for the femoral cannula? 61
International Survey on Extracorporeal Membrane Oxygenation Transport 61
Clinical significance of a new Q wave after cardiac surgery 60
Beating-heart coronary artery bypass graft surgery at San Raffaele Hospital: four years of experience 60
The ELSO Maastricht Treaty for ECLS Nomenclature: abbreviations for cannulation configuration in extracorporeal life support - a position paper of the Extracorporeal Life Support Organization 60
COMPARATIVE ANALYSIS OF THE THROMBOGENIC POTENTIAL OF THE HEARTMATE 3 AND HEARTWARE HVAD CARDIAC PUMPS: A “NUMERICAL RATIONALE” OF CLINICAL OUTCOMES 60
Minimally invasive closed circuit versus standard extracorporeal circulation for aortic valve replacement 60
Mid-term results of tricuspid annuloplasty with a three-dimensional remodelling ring 59
Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials 59
Intracardiac clots masked by extracorporeal membrane oxygenation venous cannula 59
Polypoid atrial myxoma 59
Lo studio IABP-SHOCK II 59
Loss of circadian rhythm in HVAD patients correlates with early diagnosis of pump thrombosis 59
Human protein C zymogen concentrate in patients with severe sepsis and multiple organ failure after adult cardiac surgery 58
Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated 58
Management of Ventricular Tachycardia in the Setting of a Dedicated Unit for the Treatment of Complex Ventricular Arrhythmias Long-Term Outcome After Ablation 58
Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO 58
Hemodynamic and echocardiographic effects of aortic regurgitation on femoro-femoral veno-arterial ECMO 58
First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries 58
Management of cardiogenic shock in acute decompensated chronic heart failure: The ALTSHOCK phase II clinical trial 58
Cardiac Valve Involvement in Systemic Diseases: A Review 58
Protein C zymogen in severe sepsis: a double-blinded, placebo-controlled, randomized study 57
Drotrecogin alpha and anticoagulants in septic patients after cardiac surgery 57
Second cross-clamping after mitral valve repair for degenerative disease in contemporary practice 57
The role of different mechanical circulatory support devices and their timing of implantation on myocardial damage and mid-term recovery in acute myocardial infarction related cardiogenic shock 57
Platelet activation is a preoperative risk factor for the development of thromboembolic complications in patients with continuous-flow left ventricular assist device 57
Recombinant activated factor VII increases stroke in cardiac surgery: a meta-analysis. 57
Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: a randomized controlled trial 56
Long-term outcome and quality of life of patients requiring prolonged mechanical ventilation after cardiac surgery 56
Management of refractory hypoxemia during venovenous extracorporeal membrane oxygenation for ARDS 56
Microfluidic approaches for the assessment of blood cell trauma: a focus on thrombotic risk in mechanical circulatory support devices 56
Coagulation Derangements in Patients With Refractory Cardiac Arrest Treated With Extracorporeal Cardiopulmonary Resuscitation 56
Mechanical Circulatory Support With Impella Percutaneous Ventricular Assist Device as a Bridge to Recovery in Takotsubo Syndrome Complicated by Cardiogenic Shock and Left Ventricular Outflow Tract Obstruction 56
Long-Term Results (<= 18 Years) of the Edge-to-Edge Mitral Valve Repair Without Annuloplasty in Degenerative Mitral Regurgitation Implications for the Percutaneous Approach 56
Coronary reactivity testing in vasospastic angina leading to cardiac arrest and coronary dissection 55
Miniaturized cardiopulmonary bypass improves short-term outcome in cardiac surgery: a meta-analysis of randomized controlled studies 55
Perioperative magnesium supplementation to prevent atrial fibrillation after off-pump coronary artery surgery: a randomized controlled study 55
Microfluidic technology for label-free platelet separation: a step forward towards the development of a Point-Of-Care diagnostic device of prothrombotic platelet function 55
Ultrasound-accelerated thrombolysis and extracorporeal membrane oxygenation in a patient with massive pulmonary embolism and cardiac arrest 55
Totale 7.170
Categoria #
all - tutte 93.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.961


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/2022124 2 0 2 53 10 14 12 11 5 2 3 10
2022/20231.189 508 255 103 7 5 155 50 50 42 3 3 8
2023/2024395 19 20 39 37 30 90 10 23 0 24 17 86
2024/20252.743 404 40 46 102 65 201 350 217 512 390 157 259
2025/20268.351 596 725 605 1.317 534 240 804 496 2.231 443 154 206
Totale 13.162